<?xml version="1.0" encoding="UTF-8"?>
<p id="Par34">Another interesting finding of the current study is that Cannabis most likely has the ability to improve sleep quality, decrease sleep disturbances, and decrease sleep onset latency (Kuhathasan et al. 
 <xref ref-type="bibr" rid="CR58">2019</xref>, Nawaz et al. 
 <xref ref-type="bibr" rid="CR86">2009</xref>). These findings align with a double-blind clinical trial, which showed success in treating chronic insomnia by using Zeliraâ€™s proprietary cannabis formulation (ZTL-101) which was on target to launch in the Australian market by early Q3 2020 (Zelira Therapeutics 
 <xref ref-type="bibr" rid="CR137">2020</xref>). Moreover, the use of cannabis to treat psychological conditions was also documented (Ahmed and Azam 
 <xref ref-type="bibr" rid="CR2">2014</xref>). A small randomized clinical trial reported clinical improvement in patients with schizophrenia treated with CBD (Iseger and Bossong 
 <xref ref-type="bibr" rid="CR47">2015</xref>), and nine ongoing clinical trials have registered which focused on the effects of CBD on psychotic disorders (Batalla et al. 
 <xref ref-type="bibr" rid="CR13">2019</xref>).
</p>
